More than 2500 participated in Spirit to Cure, undertaking a 21km walk, 350km ride or personal fitness challenge, with the aim of changing the lives of cancer patients and their families. The Australian events were held in partnership with Tour de Cure, while the Kiwis supported Leukaemia & Blood Cancer NZ, and Cancer Research Trust NZ.
The $1.7 million will fund pioneering research into the diagnosis and treatment of cancer, as well as support programs to improve the day-to-day life of people affected by cancer.
One of the grant recipients this year was the Smiling for Smiddy Cell Cycle Research Group at the Mater Research Institute. Lead of the Research Group, Professor Brian Gabrielli, shared how the funds will support their studies into melanomas and developing drugs for clinical use.
“We have found a defect that is common in many cancer types – while melanoma is the one we have specifically been working on, we know that ovarian cancers and lung cancers have the same defect," he said.
"We are able to specifically target the tumours with a combination of molecules… and hopefully we can develop this into something that is really going to make a difference."